keyword
https://read.qxmd.com/read/38632015/variability-of-fibrinolytic-activity-in-pregnant-patients-exposed-to-tissue-plasminogen-activator-an-in-vitro-study-utilizing-rotational-thromboelastometry
#1
JOURNAL ARTICLE
A Tran, D Katz
BACKGROUND: The investigation into the variability of fibrinolysis in obstetric patients is notably limited despite its relevance to postpartum hemorrhage. We investigate an in vitro model of fibrinolysis measured by rotational thromboelastrometry (ROTEM) in maternal blood samples with lysis stimulated by tissue plasminogen activator (tPA). METHODS: Written informed consent was obtained from 19 patients at term pregnancy during admission to the labor and delivery unit...
March 26, 2024: International Journal of Obstetric Anesthesia
https://read.qxmd.com/read/38511530/immunological-parameters-of-maternal-peripheral-blood-as-predictors-of-future-pregnancy-outcomes-in-patients-with-unexplained-recurrent-pregnancy-loss
#2
JOURNAL ARTICLE
Yingrong Li, Irene X Y Wu, Xuan Wang, Jinlu Song, Quan Chen, Weiru Zhang
INTRODUCTION: Unexplained recurrent pregnancy loss (URPL), affecting approximately 1%-5% of women, exhibits a strong association with various maternal factors, particularly immune disorders. However, accurately predicting pregnancy outcomes based on the complex interactions and synergistic effects of various immune parameters without an automated algorithm remains challenging. MATERIAL AND METHODS: In this historical cohort study, we analyzed the medical records of URPL patients treated at Xiangya Hospital, Changsha, China, between January 2020 and October 2022...
March 21, 2024: Acta Obstetricia et Gynecologica Scandinavica
https://read.qxmd.com/read/38462250/the-role-of-viscoelastic-hemostatic-assays-for-postpartum-hemorrhage-management-and-bedside-intrapartum-care
#3
REVIEW
Daniel Katz, Michaela Farber, Chloe Getrajdman, Joshua Hamburger, Sharon Reale, Alexander Butwick
Viscoelastic hemostatic assays are point-of-care devices that assess coagulation and fibrinolysis in whole blood samples. These technologies provide numeric and visual information of clot initiation, clot strength, and clot lysis under low-shear conditions, and have been used in a variety of clinical settings and subpopulations, including trauma, cardiac surgery, and obstetrics. Emerging data indicate that these devices are useful for detecting important coagulation defects during major postpartum hemorrhage (especially low plasma fibrinogen concentration [hypofibrinogenemia]) and informing clinical decision-making for blood product use...
March 2024: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/38182562/quick-model-based-viscoelastic-clot-strength-predictions-from-blood-protein-concentrations-for-cybermedical-coagulation-control
#4
JOURNAL ARTICLE
Damon E Ghetmiri, Alessia J Venturi, Mitchell J Cohen, Amor A Menezes
Cybermedical systems that regulate patient clotting in real time with personalized blood product delivery will improve treatment outcomes. These systems will harness popular viscoelastic assays of clot strength such as thromboelastography (TEG), which help evaluate coagulation status in numerous conditions: major surgery (e.g., heart, vascular, hip fracture, and trauma); liver cirrhosis and transplants; COVID-19; ICU stays; sepsis; obstetrics; diabetes; and coagulopathies like hemophilia. But these measurements are time-consuming, and thus impractical for urgent care and automated coagulation control...
January 5, 2024: Nature Communications
https://read.qxmd.com/read/37973317/viscoelastic-testing-methods
#5
JOURNAL ARTICLE
Timothy Carll
Viscoelastic testing methods examine the real-time formation of a clot in a whole blood sample, and include thromboelastography (TEG), rotational thromboelastometry (ROTEM), and several other testing platforms. They allow for concurrent assessment of multiple aspects of clotting, including plasmatic coagulation factors, platelets, fibrinogen, and the fibrinolytic pathway. This testing is rapid and may be performed at the point-of-care, allowing for prompt identification of coagulopathies to guide focused and rational administration of blood products as well as the identification of anticoagulant effect...
2023: Advances in Clinical Chemistry
https://read.qxmd.com/read/37362492/thromboelastography-in-the-perioperative-period-a-literature-review
#6
REVIEW
Vendhan Ramanujam, Stephen DiMaria, Vivek Varma
Assessing coagulation status is essential for prompt intervention to reduce morbidity and mortality related to bleeding and thrombotic complications during the perioperative period. Traditional coagulation tests such as platelet count, activated partial thromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR), and activated clotting time (ACT) provide only static evaluation. These tests are not designed for assessment of dynamically changing coagulation conditions during the perioperative time...
May 2023: Curēus
https://read.qxmd.com/read/37336216/critical-care-in-placenta-accreta-spectrum-disorders-a-call-to-action
#7
JOURNAL ARTICLE
Cesar R Padilla, Amir A Shamshirsaz, Sarah R Easter, Phillip Hess, Carly Smith, Nadir El Sharawi, Adam T Sandlin
The rising in placenta accreta spectrum (PAS) incidence, highlights the need for critical care allotment for these patients. Due to risk for hemorrhage and possible hemorrhagic shock requiring blood product transfusion, hemodynamic instability and risk of end-organ damage, having an intensive care unit (ICU) with surgical expertise (surgical ICU or equivalent based on institutional resources) is highly recommended. Intensive care units physicians and nurses should be familiarized with intraoperative anesthetic and surgical techniques as well as obstetrics physiologic changes to provide postpartum management of PAS...
July 2023: American Journal of Perinatology
https://read.qxmd.com/read/37283995/review-of-current-insights-and-therapeutic-approaches-for-the-treatment-of-refractory-postpartum-hemorrhage
#8
REVIEW
Lilly Y Liu, Lisa Nathan, Jean-Ju Sheen, Dena Goffman
Refractory postpartum hemorrhage (PPH) affects 10-20% of patients with PPH when they do not respond adequately to first-line treatments. These patients require second-line interventions, including three or more uterotonics, additional medications, transfusions, non-surgical treatments, and/or surgical intervention. Multiple studies have suggested that patients with refractory PPH have different clinical characteristics and causes of PPH when compared to patients who respond to first-line agents. This review highlights current insights into therapeutic approaches for the management of refractory PPH...
2023: International Journal of Women's Health
https://read.qxmd.com/read/37089113/novel-risk-prediction-models-involving-coagulation-thromboelastography-stress-response-and-immune-function-indicators-for-deep-vein-thrombosis-after-radical-resection-of-cervical-cancer-and-ovarian-cancer
#9
JOURNAL ARTICLE
Jing Zhang, Jia Chen, Xiuqing Yang, Jing Han, Xiaofeng Chen, Yueping Fan, Hui Zheng
This study aimed to investigate the predictive value of coagulation, thromboelastography, stress response, and immune function indicators for the occurrence of deep venous thrombosis (DVT) following radical resection of cervical cancer and ovarian cancer. We conducted a prospective, single-centre, case-control study that included 230 cervical cancer patients and 230 ovarian cancer patients. In the testing cohort, the final predictive model for cervical cancer patients was: Logit(P)=9.365-0.063(R-value)-0.112(K value) +0...
December 2023: Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology
https://read.qxmd.com/read/36855088/hellp-syndrome-intracerebral-hemorrhage-and-hemophagocytic-syndrome-after-cesarean-section-in-a-pregnant-patient-with-severe-preeclampsia-a-case-report
#10
JOURNAL ARTICLE
Minghe Tan, Siqi Wang, Qingshu Li, Ruixue Yuan, Maoji Zhao, Jun Cao
BACKGROUND: Pregnancy-related intracranial hemorrhage (ICH) is a rare but potentially life-threatening event with complex and varied cause, such as HELLP syndrome and hemophagocytic syndrome. CASE PRESENTATION: A 33-year-old patient underwent a cesarean section with a preliminary diagnosis of "severe preeclampsia and class3 HELLP syndrome ". The patient had poor response to language before surgery, and the catheter drainage fluid was hematuria. Later, the surgeon reported severe bleeding in the operation...
February 28, 2023: BMC Pregnancy and Childbirth
https://read.qxmd.com/read/36760779/viscoelastic-testing-an-illustrated-review-of-technology-and-clinical-applications
#11
REVIEW
Jan Hartmann, Daniela Hermelin, Jerrold H Levy
Viscoelastic testing (VET), including thromboelastography and thromboelastometry, provides a rapid and comprehensive picture of whole blood coagulation dynamics and hemostasis that can be reviewed and evaluated at the point-of-care. This technology is over 50 years old; however, over the past few years, there has been a significant increase in research examining the use of VET. Best practice guidelines for the use of VET exist in both the United States and Europe, particularly for elective cardiac surgery, although recommendations for implementation are somewhat limited in some clinical areas by the lack of studies constituting high-grade evidence...
January 2023: Research and Practice in Thrombosis and Haemostasis
https://read.qxmd.com/read/36756665/clinical-phenotype-treatment-strategy-and-pregnancy-outcome-of-non-criteria-obstetric-antiphospholipid-syndrome
#12
JOURNAL ARTICLE
Jiapo Li, Yue Hou, Liyang Zhang, Fan Li, Qian Liu, Yuanyuan Li, Hongfei Shen, Ziyue Xiong, Ling Huang, Chong Qiao
PROBLEM: To illustrate the clinical features, treatment strategy, and pregnancy outcome of patients with obstetric antiphospholipid syndrome (OAPS), non-criteria obstetric antiphospholipid syndrome (NC-OAPS) METHOD OF STUDY: A single-center nested case-control study was designed. Patients with a diagnosis of OAPS and NC-OAPS were enrolled. The medical history, coagulation status, and antibody profile data were collected. Patients were given standard anticoagulation therapy with or without glucocorticoids (GC) and/or hydroxychloroquine (HCQ) during pregnancy and were observed for their pregnancy outcome...
June 2023: American Journal of Reproductive Immunology: AJRI
https://read.qxmd.com/read/36273811/comparative-retrospective-study-on-the-validity-of-point-of-care-testing-device-for-massive-obstetrical-hemorrhage-dry-hematology-vs-thromboelastography
#13
JOURNAL ARTICLE
Eishin Nakamura, Shigetaka Matsunaga, Akihiko Kikuchi, Yasushi Takai
BACKGROUND: Early recognition of hypofibrinogenemia and prompt initiation of transfusion therapy in patients with massive obstetrical hemorrhage can improve prognosis. There are reports on the usefulness of point-of-care testing, which provides quicker test results compared with fibrinogen measurements using the conventional Clauss method. OBJECTIVE: This study aimed to compare and investigate the diagnostic accuracy of dry hematology and thromboelastography in point-of-care testing for the diagnosis of hypofibrinogenemia...
January 2023: American journal of obstetrics & gynecology MFM
https://read.qxmd.com/read/36122976/postpartum-hemorrhage-management-and-blood-component-therapy
#14
REVIEW
Katie W Zeng, Kelsie J Ovenell, Zachary Alholm, Michael R Foley
This article serves to highlight both the common nature and severity of postpartum hemorrhage (PPH). Identification of etiologies and management of each is reviewed. In addition, the evaluation and administration of proper blood component therapies and massive transfusion are also explained to help providers become comfortable with early administration and delivery of blood component therapies.
September 2022: Obstetrics and Gynecology Clinics of North America
https://read.qxmd.com/read/36075527/emerging-technology-for-early-detection-and-management-of-postpartum-hemorrhage-to-prevent-morbidity
#15
REVIEW
Megan G Lord, Joaquin A Calderon, Homa K Ahmadzia, Luis D Pacheco
Despite advances in hemorrhage detection and management, postpartum hemorrhage remains the single leading cause of maternal death worldwide. Within the United States, hemorrhage is the leading cause of maternal death on the day of delivery and within the first week after delivery. Blood transfusion after hemorrhage represents a large proportion of severe maternal morbidity during and after delivery. Blood loss during delivery has historically been assessed visually by inspecting soiled pads, linens, and laparotomy sponges...
September 6, 2022: American journal of obstetrics & gynecology MFM
https://read.qxmd.com/read/35845226/platelet-storage-pool-disorder-in-pregnancy-utilising-thromboelastography-to-guide-a-risk-based-delivery-plan
#16
Timothy Ac Snow, Rezan A Abdul-Kadir, Keith Gomez, Adrian England
We present a case of a 33-year-old woman in her third pregnancy diagnosed with platelet storage pool disorder who had previously suffered two postpartum major obstetric haemorrhages. Platelet storage pool disorder is a rare bleeding disorder where the platelet count is normal but platelet function is impaired due to deficiency of dense granules. A peripartum plan devised by an extensive multi-disciplinary team using principles for managing other bleeding and platelet function disorders helped minimise her risk of major haemorrhage...
June 2022: Obstetric Medicine
https://read.qxmd.com/read/35115430/point-of-care-viscoelastic-tests-in-the-management-of-obstetric-hemorrhage
#17
JOURNAL ARTICLE
David B Nelson, Olutoyosi Ogunkua, F Gary Cunningham
Obstetric hemorrhage remains the leading cause of maternal morbidity and mortality worldwide. Thromboelastography and rotational thromboelastometry are laboratory methods of assessing the kinetics of blood clot formation through real-time measurement of viscoelastic clot strength and may aid in management of severe hemorrhage. Although first described more than 70 years ago, viscoelastic testing devices are now available that allow for rapid point-of-care use of this technology to aid in real-time management of blood product replacement in cases of severe hemorrhage...
March 1, 2022: Obstetrics and Gynecology
https://read.qxmd.com/read/34870482/impact-of-intraoperative-salvaged-blood-autotransfusion-during-obstetric-hemorrhage-on-the-coagulation-function-a-retrospective-cohort-analysis
#18
JOURNAL ARTICLE
Ling Sun, Ying Xu, Lingfei Huang
OBJECTIVE: This study aimed to explore the effect of intraoperative blood salvage (autotransfusion) on coagulation function in the rescue of an obstetric hemorrhage. METHODS: A total of 65 pregnant women who were diagnosed with placenta previa in our Hospital and gave birth in the hospital were enrolled in the study. All the patients underwent thromboelastography, routine blood tests, and blood coagulation series + D-dimer before and within 30 min of the autologous blood transfusion...
January 2021: Clinical and Applied Thrombosis/hemostasis
https://read.qxmd.com/read/34501395/viscoelastic-hemostatic-assays-for-postpartum-hemorrhage
#19
REVIEW
Alyson E Liew-Spilger, Nikki R Sorg, Toby J Brenner, Jack H Langford, Margaret Berquist, Natalie M Mark, Spencer H Moore, Julie Mark, Sara Baumgartner, Mary P Abernathy
This article discusses the importance and effectiveness of viscoelastic hemostatic assays (VHAs) in assessing hemostatic competence and guiding blood component therapy (BCT) in patients with postpartum hemorrhage (PPH). In recent years, VHAs such as thromboelastography and rotational thromboelastometry have increasingly been used to guide BCT, hemostatic adjunctive therapy and prohemostatic agents in PPH. The three pillars of identifying hemostatic competence include clinical observation, common coagulation tests, and VHAs...
August 31, 2021: Journal of Clinical Medicine
https://read.qxmd.com/read/33993506/successful-extracorporeal-cardiopulmonary-resuscitation-for-a-puerpera-with-amniotic-fluid-embolism
#20
JOURNAL ARTICLE
Jia Mingwang, Zhaohui Gan, Luo Xitu, Han Xie, Yichun Wang, Dunjin Chen
Amniotic fluid embolism (AFE) is one of many high-mortality maternal complications, with approximately 50% of patients with AFE suffering cardiac arrest [1]. Additionally, 89% of deaths in cases of amniotic fluid embolism are caused by cardiac arrest, and there are no statistical data for refractory cardiac and respiratory arrest [2].
May 16, 2021: International Journal of Gynaecology and Obstetrics
keyword
keyword
59335
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.